ESSA Pharma Inc
NASDAQ:EPIX
Gross Margin
ESSA Pharma Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Gross Margin Comparison
ESSA Pharma Inc Competitors
Country | CA |
Market Cap | 279.1m USD |
Gross Margin | N/A |
Country | US |
Market Cap | 293.9B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 144B USD |
Gross Margin |
70%
|
Country | US |
Market Cap | 101.6B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 98.1B USD |
Gross Margin |
86%
|
Country | AU |
Market Cap | 130.2B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 83.2B USD |
Gross Margin |
78%
|
Country | US |
Market Cap | 43.1B USD |
Gross Margin |
75%
|
Country | US |
Market Cap | 38.7B USD |
Gross Margin |
31%
|
Country | US |
Market Cap | 28.2B USD |
Gross Margin |
74%
|
Country | IE |
Market Cap | 26.6B USD |
Gross Margin |
75%
|
Profitability Report
View the profitability report to see the full profitability analysis for ESSA Pharma Inc.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on ESSA Pharma Inc's most recent financial statements, the company has Gross Margin of 0%.